OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Law Group announces that a lawsuit has been filed against Amylyx Pharmaceuticals, Inc. (“Amylyx Pharmaceuticals”) (NASDAQ: AMLX), on behalf of investors who purchased or acquired shares between November 11, 2022, and November 8, 2023. What Should Amylyx Pharmaceuticals Investors Do? If you invested in Amylyx Pharmaceuticals, visit our website by clicking here, or call us toll-free at (888) 410- 2925 to discuss how you may be able to recover your losses. Our investigat ...